Anoro(TM) Ellipta(R) Now Available in the US for Treatment of COPD

Anoro Ellipta is a combination anticholinergic/long-acting beta2-adrenergic agonist indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.

http://ift.tt/S1m6Tv